Chromatography

QNTM Labs Announces EU-GMP Certified Expansion to Meet Growing Industry Needs

Retrieved on: 
Tuesday, November 7, 2023
Mettler Toledo, Certification, Drug development, Mass spectrometry, Trust, Microbiology, Agilent Technologies, GMP, EU, Chromatography, Fine chemical

ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.

Key Points: 
  • ODENSE, Denmark, Nov. 7, 2023 /PRNewswire/ -- QNTM Labs is pleased to announce the significant expansion to its existing headquarters.
  • This expansion serves as a testament to the trust and success accrued from client engagements since the initial GMP certification.
  • Cornelius Merlini, Managing Partner at Intrinsic Capital Partners, reflects, "QNTM Labs' expanded EU-GMP certifications showcase their unwavering commitment to quality and compliance.
  • With this expansion, QNTM Labs is better positioned to address the evolving analytical requirements of the pharmaceutical industry, both within Denmark and across the broader European market.

Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device

Retrieved on: 
Thursday, November 2, 2023
Filtration, Dicarboxylic acid, Repligen Corporation Award in Chemistry of Biological Processes, Chromatography, CNC, Senior, Repligen, Cross-flow filtration, Risk, Spacecraft, Ultrafiltration, Safety, PRO, TFF, SC, Cassette tape

WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.

Key Points: 
  • WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device.
  • Christine Gebski, Senior Vice President, Filtration and Chromatography at Repligen, said, “TangenX SC pushes the boundaries of TFF innovation, offering clear advantages to virtually any user of flat sheet TFF.
  • The holder-free TangenX SC device simplifies and streamlines downstream flat sheet UF/DF processes like never before.
  • Designed with the same flow path length and channel geometry as traditional cassettes, TangenX SC allows users to seamlessly transition from traditional cassettes.

Calibre Scientific Acquires CPS Analitica, a Provider of Chromatography Consumables in Italy

Retrieved on: 
Monday, October 30, 2023
HPLC, Acquisition, Geography, CPS, GC, Chromatography, Fine chemical

LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of C.P.S.

Key Points: 
  • LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of C.P.S.
  • (“CPS” or the “Company”), an Italian provider of chromatography consumables for the pharmaceutical, biotech, life sciences, academic, food & beverage, environmental and chemical industries.
  • CPS is Calibre Scientific’s first acquisition in Italy, further expanding its presence in Europe and bolstering its overall product portfolio in the chromatography space.
  • We are excited to welcome CPS Analitica to the Calibre Scientific family.”
    “We are delighted to join Calibre Scientific,” said Roberto Miglio, Managing Director of CPS.

Proteomics Reagents Dominate Market, While Drug Discovery Applications Exhibit Highest Growth Rate - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 1, 2023
Biotechnology, Pharmaceutical, Health, Research, Growth, Proteomics, Chromatography, Government, Drug discovery, Prevalence, End, Protein microarray, Developed country, Protein, R, Artificial intelligence, Genomics, COVID-19, DSM-IV codes, Hospital, Traction, TAT, Surface plasmon resonance, Instrument, Patient, Medical device, Pharmaceutical industry, Fine chemical, Electrophoresis, Investment, Cancer

Faster Turn-around Times (TAT): Proteomics technologies enable faster turn-around times in diagnostics and drug discovery, facilitating quicker patient management and pharmaceutical development.

Key Points: 
  • Faster Turn-around Times (TAT): Proteomics technologies enable faster turn-around times in diagnostics and drug discovery, facilitating quicker patient management and pharmaceutical development.
  • Increased Investments in R&D in the Field of Proteomics: Research and development activities in proteomics have witnessed significant investments, driving innovation and market growth.
  • Surge in Drug Discovery: Proteomics technologies are increasingly being used to accelerate drug discovery processes, leading to the development of novel therapeutic agents.
  • The drug discovery segment is also expected to exhibit the highest CAGR in the future, as proteomics technologies offer early insights into drug discovery programs, saving pharmaceutical companies significant capital and benefiting patients and healthcare systems.

Global Downstream Processing Market Size, Share & Trends Analysis Report 2023: Chromatography Systems Segment Dominated in 2022 with 41.29% Market Share - Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, October 27, 2023
Science, Biotechnology, Research, Pharmaceutical, Medical Supplies, Health, Infectious Diseases, Clinical Trials, Food and Bioprocess Technology, Purification, Vaccine, Government, Membrane, Acquisition, Application, Repligen, Growth, COVID-19, Filter, Partnership, Traction, USD, Investment, Titanium, Chromatography, Automation, Fine chemical, Speciality chemicals, Pharmaceutical industry

The "Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Purification, Formulation), By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Downstream Processing Market Size, Share & Trends Analysis Report By Product (Chromatography Systems, Filters), By Technique (Purification, Formulation), By Application, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global downstream processing market size is expected to reach USD 94.79 billion by 2030.
  • This expansion is set to unfold at an impressive compound annual growth rate (CAGR) of 14.84% from 2023 to 2030.
  • Notably, the surge in downstream processing techniques' adoption for COVID-19 vaccine development has played a pivotal role in propelling market growth.

Purdue Research Foundation Terminates Medallion’s License to Use Lad Chromatography

Retrieved on: 
Wednesday, October 18, 2023
CFO, MDL, Purdue University, Chromatography, Management

VANCOUVER, British Columbia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that its license to use ligand assisted displacement chromatography has terminated.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that its license to use ligand assisted displacement chromatography has terminated.
  • The Medallion Board and management will consider next steps in light of this development.
  • Separately, Douglas Newby has given notice of his resignation as Chief Financial Officer but has agreed to continue to serve for up to 30 days on an interim basis pending appointment of a new CFO.
  • Rod McKeen, Chairman, thanked Mr. Newby for all his efforts and hard work including working closely with the technical team that sought to achieve the technical and financial milestones under the Purdue technology license.

Laboratory Gas Generators Market to be worth USD 1.27 Billion by 2031: Exclusive Report by Transparency Market Research

Retrieved on: 
Wednesday, October 18, 2023
Laboratory, PEAK, LC-MS, Organization, Research, Mass spectrometry, Carbon footprint, Motoren Technik Mayer, Peak Scientific, Biotechnology, Transport, Risk, Marketing, Accident, Safety, GC, Gas, Greenhouse, Chromatography, Automation, Instrumentation, Renewable energy, Propane, Industrial gas

WILMINGTON, Del., Oct. 18, 2023 /PRNewswire/ -- TMR predicts the laboratory gas generators market is expected to reach US$ 1.27 billion by 2031. The market is predicted to expand at an 11% CAGR through 2031. Gas generators can now be monitored and controlled remotely using IoT (Internet of Things) technology. By using this feature, laboratories can monitor their gas usage, detect maintenance issues, and optimize their workflow.

Key Points: 
  • Sustainable practices and environmental concerns have led to the development of energy-efficient laboratory gas generators that produce zero greenhouse gases.
  • Enquiry Before Buying this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep...
    Global Laboratory Gas Generators Market: Growth Drivers
    The use of gas generators saves laboratories time and money by replacing gas cylinders and allowing them to order and store high-purity gases on demand.
  • Handling and storing high-pressure gas cylinders are no longer risks for laboratories with laboratory gas generators.
  • Global Laboratory Gas Generators Market: Regional Landscape
    North America dominates the laboratory gas generator market.

Laboratory Gas Generators Market to be worth USD 1.27 Billion by 2031: Exclusive Report by Transparency Market Research

Retrieved on: 
Wednesday, October 18, 2023
Laboratory, PEAK, LC-MS, Organization, Research, Mass spectrometry, Carbon footprint, Motoren Technik Mayer, Peak Scientific, Biotechnology, Transport, Risk, Marketing, Accident, Safety, GC, Gas, Greenhouse, Chromatography, Automation, Instrumentation, Renewable energy, Propane, Industrial gas

WILMINGTON, Del., Oct. 18, 2023 /PRNewswire/ -- TMR predicts the laboratory gas generators market is expected to reach US$ 1.27 billion by 2031. The market is predicted to expand at an 11% CAGR through 2031. Gas generators can now be monitored and controlled remotely using IoT (Internet of Things) technology. By using this feature, laboratories can monitor their gas usage, detect maintenance issues, and optimize their workflow.

Key Points: 
  • Sustainable practices and environmental concerns have led to the development of energy-efficient laboratory gas generators that produce zero greenhouse gases.
  • Enquiry Before Buying this Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep...
    Global Laboratory Gas Generators Market: Growth Drivers
    The use of gas generators saves laboratories time and money by replacing gas cylinders and allowing them to order and store high-purity gases on demand.
  • Handling and storing high-pressure gas cylinders are no longer risks for laboratories with laboratory gas generators.
  • Global Laboratory Gas Generators Market: Regional Landscape
    North America dominates the laboratory gas generator market.

Medallion Receives Notice of Default From Purdue Research Foundation

Retrieved on: 
Tuesday, October 10, 2023
Purdue Research Park, MDL, PRF, Chromatography, Rare-earth element, Medical device, Credit

VANCOUVER, British Columbia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that it has received notice of default from Purdue Research Foundation (“PRF”) and has until October 17, 2023 to cure the default or the Company’s license to use ligand assisted displacement chromatography will be terminated.

Key Points: 
  • VANCOUVER, British Columbia, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Medallion Resources Ltd. (TSX-V: MDL; OTCQB: MLLOF; Frankfurt: MRDN) – “Medallion” or the “Company”) announced today that it has received notice of default from Purdue Research Foundation (“PRF”) and has until October 17, 2023 to cure the default or the Company’s license to use ligand assisted displacement chromatography will be terminated.
  • The Company is in discussion with PRF about curing the default or extending the term but there is no assurance that those discussions will be successful.

AGC Biologics Completes pDNA and mRNA Line Expansion in Heidelberg

Retrieved on: 
Thursday, October 12, 2023
Stem Cells, Biotechnology, Manufacturing, Health, Pharmaceutical, Health Technology, Research, Genetics, Engineering, Science, Chemicals, Plastics, Plasmid, DNA, GMP, Messenger, CDMO, RNA, AGC, Fermentation, Chromatography, API, Vaccine

AGC Biologics , a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at the CDMO’s Heidelberg, Germany site.

Key Points: 
  • AGC Biologics , a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facility expansion for its new plasmid DNA (pDNA) and messenger RNA (mRNA) production line at the CDMO’s Heidelberg, Germany site.
  • With this expansion and added production line, AGC Biologics can now offer more plasmid material in high-quality and GMP grades and expand the services it offers for mRNA supply.
  • The addition to the Heidelberg facility utilizes state-of-the-art single-use equipment, creating the flexibility to produce different projects simultaneously with shorter timelines and faster project turnover – allowing AGC Biologics to serve more developers in need of pDNA and mRNA materials.
  • AGC Biologics leveraged this knowledge to establish and grow its global pDNA and mRNA services at the site.